Defense World
30 Dec 2025, 10:14 UTC · 43w ago
Allarity Therapeutics, Inc. (NASDAQ:ALLR) Short Interest Down 21.9% in December
Impact · against what's priced in
The decrease in short interest for Allarity Therapeutics is not a material catalyst. With only 1.7% of shares sold short, the bearish conviction was already negligible and unlikely to influence the stock price.
- ALLR+0.00
No priced-in read yet
- In context
A 21.9% drop in short interest is mathematically insignificant because the total short interest remains at a negligible 1.7% of shares outstanding.
Read from the article alone
Search tags
